Instituto Di Ricovero E Cura A Carattere Scientifico
- Address
- Via Pilastroni 4, 25125 Brescia, Italy
Diseases [C] - Nervous System Diseases
At Instituto Di Ricovero E Cura A Carattere Scientifico in Brescia, the clinical research focus is centered on neurology, with studies exploring major neurodegenerative diseases such as Alzheimer's disease and frontotemporal dementia. The trials are designed to assess whether new treatments can better support patients living with these progressive brain disorders.
- Frontotemporal dementia research focused on testing a new therapy for symptom control and overall clinical benefit
- Alzheimer's disease studies aimed at evaluating treatment safety, brain-related effects, and potential disease modification
This site contributes to efforts in improving both treatment effectiveness and the understanding of how emerging therapies may help slow or manage cognitive decline.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Instituto Di Ricovero E Cura A Carattere Scientifico
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of ABBV-916 in Subjects with Early Alzheimer's Disease | AbbVie Deutschland GmbH & Co. KG | Phase II | Not Recruiting | — | Jun 2024 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Florquinitau (18F) | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.